Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for International Journal of Genomics, enter your email address in the box below.

International Journal of Genomics
Volume 2013 (2013), Article ID 609748, 10 pages
http://dx.doi.org/10.1155/2013/609748
Research Article

DUSP1 Gene Polymorphisms Are Associated with Obesity-Related Metabolic Complications among Severely Obese Patients and Impact on Gene Methylation and Expression

F. Guénard,1,2,3 L. Bouchard,4 A. Tchernof,2,3 Y. Deshaies,5,6 F. S. Hould,7 S. Lebel,7 P. Marceau,7 L. Pérusse,1,3,8 and M. C. Vohl1,2,3

1Institute of Nutrition and Functional Foods (INAF), Laval University, Québec, QC, Canada G1V 0A6
2Department of Food Science and Nutrition, Laval University, Québec, QC, Canada G1V 0A6
3Endocrinology and Nephrology, CHU de Québec Research Center, Québec, QC, Canada G1V 4G2
4Department of Biochemistry, Université de Sherbrooke, ECOGENE-21, Chicoutimi Hospital, Saguenay, Canada G7H 7P2
5Department of Medicine, Laval University, Québec, QC, Canada G1V 0A6
6Québec Heart and Lung Institute, Québec, QC, Canada G1V 4G5
7Department of Surgery, Laval University, Québec, QC, Canada G1V 0A6
8Department of Kinesiology, Laval University, Québec, QC, Canada G1V 0A6

Received 3 May 2013; Accepted 11 July 2013

Academic Editor: Sinan Tanyolaç

Copyright © 2013 F. Guénard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Mokdad, E. S. Ford, B. A. Bowman et al., “Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001,” Journal of the American Medical Association, vol. 289, no. 1, pp. 76–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Tirosh, I. Shai, A. Afek et al., “Adolescent BMI trajectory and risk of diabetes versus coronary disease,” The New England Journal of Medicine, vol. 364, no. 14, pp. 1315–1325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lafontan and J. Girard, “Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue,” Diabetes and Metabolism, vol. 34, no. 4, part 1, pp. 317–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J.-P. Després, “Visceral obesity the link among inflammation, hypertension, and cardiovascular disease,” Hypertension, vol. 53, no. 4, pp. 577–584, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  6. A. D. Karelis, D. H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E. T. Poehlman, “Metabolic and body composition factors in subgroups of obesity: what do we know?” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2569–2575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Otani, “Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome,” Antioxidants and Redox Signaling, vol. 15, no. 7, pp. 1911–1926, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. R. Romeo, J. Lee, and S. E. Shoelson, “Metabolic syndrome, insulin resistance, and roles of inflammation—mechanisms and therapeutic targets,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1771–1776, 2012. View at Google Scholar
  9. M. Teran-Garcia and C. Bouchard, “Genetics of the metabolic syndrome,” Applied Physiology, Nutrition, and Metabolism, vol. 32, no. 1, pp. 89–114, 2007. View at Google Scholar
  10. L. Bouchard, A. Tchernof, Y. Deshaies et al., “ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics,” Obesity Surgery, vol. 17, no. 3, pp. 372–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Abraham and A. R. Clark, “Dual-specificity phosphatase 1: a critical regulator of innate immune responses,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1018–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Kracht and J. Saklatvala, “Transcriptional and post-transcriptional control of gene expression in inflammation,” Cytokine, vol. 20, no. 3, pp. 91–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Saklatvala, J. Dean, and A. Clark, “Control of the expression of inflammatory response genes,” Biochemical Society Symposium, no. 70, pp. 95–106, 2003. View at Google Scholar · View at Scopus
  14. Y. Yin, Y. Terauchi, G. G. Solomon et al., “Involvement of p85 in p53-dependent apoptotic response to oxidative stress,” Nature, vol. 391, no. 6668, pp. 707–710, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-J. Bang, J. H. Kwon, S. H. Kang, J. W. Kim, and Y. C. Yang, “Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma,” Biochemical and Biophysical Research Communications, vol. 250, no. 1, pp. 43–47, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Vicent, M. Garayoa, J. M. López-Picazo et al., “Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients,” Clinical Cancer Research, vol. 10, no. 11, pp. 3639–3649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-Y. Wang, Z. Cheng, and C. C. Malbon, “Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer,” Cancer Letters, vol. 191, no. 2, pp. 229–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. D. F. Calvisi, F. Pinna, F. Meloni et al., “Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma,” Cancer Research, vol. 68, no. 11, pp. 4192–4200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. E. Rauhala, K. P. Porkka, T. T. Tolonen, P. M. Martikainen, T. L. J. Tammela, and T. Visakorpi, “Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer,” International Journal of Cancer, vol. 117, no. 5, pp. 738–745, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Shimada, M. Nakamura, E. Ishida et al., “c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas,” American Journal of Pathology, vol. 171, no. 3, pp. 1003–1012, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Tsujita, A. Taketomi, T. Gion et al., “Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma,” Oncology, vol. 69, no. 4, pp. 342–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Marceau, F.-S. Hould, S. Simard et al., “Biliopancreatic diversion with duodenal switch,” World Journal of Surgery, vol. 22, no. 9, pp. 947–954, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Robitaille, J.-P. Després, L. Pérusse, and M.-C. Vohl, “The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study,” Clinical Genetics, vol. 63, no. 2, pp. 109–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. I. W. De Bakker, R. Yelensky, I. Pe'Er, S. B. Gabriel, M. J. Daly, and D. Altshuler, “Efficiency and power in genetic association studies,” Nature Genetics, vol. 37, no. 11, pp. 1217–1223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Cartharius, K. Frech, K. Grote et al., “MatInspector and beyond: promoter analysis based on transcription factor binding sites,” Bioinformatics, vol. 21, no. 13, pp. 2933–2942, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Quandt, K. Frech, H. Karas, E. Wingender, and T. Werner, “Matlnd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data,” Nucleic Acids Research, vol. 23, no. 23, pp. 4878–4884, 1995. View at Google Scholar · View at Scopus
  28. M. G. Reese, F. H. Eeckman, D. Kulp, and D. Haussler, “Improved splice site detection in Genie,” Journal of Computational Biology, vol. 4, no. 3, pp. 311–323, 1997. View at Google Scholar
  29. H. Chi, S. P. Barry, R. J. Roth et al., “Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2274–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. B. B. Duncan, M. I. Schmidt, J. S. Pankow et al., “Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study,” Diabetes, vol. 52, no. 7, pp. 1799–1805, 2003. View at Google Scholar · View at Scopus
  31. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Google Scholar · View at Scopus
  32. P. Barter, Y. R. McPherson, K. Song et al., “Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2041–2045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Clarke, J. R. Emberson, E. Breeze et al., “Biomarkers of inflammation predict both vascular and non-vascular mortality in older men,” European Heart Journal, vol. 29, no. 6, pp. 800–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Pineda, F. Marín, P. Marco et al., “Premature coronary artery disease in young (age < 45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers,” International Journal of Cardiology, vol. 136, no. 2, pp. 222–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. J. V. Ponomarenko, G. V. Orlova, T. I. Merkulova et al., “rSNP_Guide: an integrated database-tools system for studying SNPs and site-directed mutations in transcription factor binding sites,” Human Mutation, vol. 20, no. 4, pp. 239–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Grundberg, K. S. Small, A. K. Hedman et al. et al., “Mapping cis- and trans-regulatory effects across multiple tissues in twins,” Nature Genetics, vol. 44, no. 10, pp. 1084–1089, 2012. View at Google Scholar
  38. J. T. Bell, A. A. Pai, J. K. Pickrell et al., “DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines,” Genome Biology, vol. 12, no. 1, article R10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. W. Drong, G. Nicholson, A. K. Hedman et al., “The presence of methylation quantitative trait Loci indicates a direct genetic influence on the level of DNA methylation in adipose tissue,” PLoS One, vol. 8, no. 2, Article ID e55923, 2013. View at Google Scholar
  40. K. Johnasson-Haque, E. Palanichamy, and S. Okret, “Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP,” Journal of Molecular Endocrinology, vol. 41, no. 3-4, pp. 239–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. C. R. Tchen, J. R. S. Martins, N. Paktiawal, R. Perelli, J. Saklatvala, and A. R. Clark, “Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence,” Journal of Biological Chemistry, vol. 285, no. 4, pp. 2642–2652, 2010. View at Publisher · View at Google Scholar · View at Scopus